ProQR Therapeutics N.V. (PRQR) Financials
PRQR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 133.8 million | 96.2 million |
| 2023-12-31 | 152.5 million | 106.8 million |
| 2023-09-30 | 150.4 million | 101.3 million |
| 2023-06-30 | 160.9 million | 104.9 million |
PRQR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -17.2 million | 794327 |
| 2023-12-31 | -9.2 million | 886575 |
| 2023-09-30 | -8.3 million | 470038 |
| 2023-06-30 | -11.6 million | 831811 |
PRQR Net Income
No data available :(
PRQR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 111.0 million | - | 16.0 million |
| 2023-12-31 | 131.6 million | - | 17.1 million |
| 2023-09-30 | 127.6 million | - | 17.0 million |
| 2023-06-30 | 139.8 million | - | 16.3 million |
PRQR Shares Outstanding
PRQR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 794659 | 10.1 million | 3.7 million | -728221 |
| 2023-12-31 | 3.2 million | 8.3 million | 5.3 million | -918853 |
| 2023-09-30 | 358880 | 5.8 million | 3.5 million | - |
| 2023-06-30 | 319676 | 6.4 million | 4.5 million | - |
PRQR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 4.8 million | 750150 |
| 2023-12-31 | 3.5 million | - |
| 2023-09-30 | 1.5 million | - |
| 2023-06-30 | 1.3 million | - |
PRQR
Price: $1.94
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.38 USD
P/E Ratio: -4.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Ebitda: -11.0 millionMarket Capitalization: 162.1 million